help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 20, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2514
A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
92/5/1956    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Körner, A.
Right arrow Articles by Kovacs, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Körner, A.
Right arrow Articles by Kovacs, P.

Submitted on November 15, 2006
Accepted on February 14, 2007

TCF7L2-gene polymorphisms confer an increased risk for early impairment of glucose metabolism and increased height in obese children

Antje Körner*, Janin Berndt, Michael Stumvoll, Wieland Kiess, and Peter Kovacs

University Hospital for Children & Adolescents, Department of Internal Medicine III, University of Leipzig, Germany

* To whom correspondence should be addressed. E-mail: antje.koerner{at}medizin.uni-leipzig.de.

Context: Variants in the transcription factor 7-like2 (TCF7L2)-gene have been associated with increased risk for type 2 diabetes in adults. To evaluate whether the five reported risk variants confer a higher risk for obesity and early impairment of glucose metabolism in children, we genotyped these risk variants of the TCF7L2-gene in a representative cohort of 1029 Caucasian children and an independent cohort of 283 obese children.

Results: Applying a case control design, we observed a significantly lower prevalence of the rs11196205 and rs7895340 risk alleles in the obese (n=283) compared to lean (n=672) children (0.40 vs. 0.45,P=0.02). There was, however, no statistical significant relationship between these genotypes and quantitative traits of obesity in neither a normal representative (n=1029) nor obesity cohort. Obese children were significantly taller than lean children. This increase in height was independently associated with risk variants of the TCF7L2-gene, while in the normal representative cohort height appeared to be decreased in carriers of the minor alleles. In the obese cohort, three risk alleles (rs7901695, rs7903146, rs1225572) were significantly associated with higher fasting and 120-min blood glucose levels independent of sex, age, pubertal stage, and BMI. Fasting and peak insulin levels and HOMA-IR appeared with a similar tendency but were not statistically significant.

Conclusions: Our data indicate for the first time that TCF7L2-gene variants confer an increased risk for early impairment of glucose metabolism in obese children, which is consistent with adult studies identifying TCF7L2 as a major diabetes susceptibility gene.


Key words: TCF7L2 • obesity • diabetes • children • height • BMI







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society